Status:
COMPLETED
D²EFT Graphical Informed Consent
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
Institute of Human Virology, Nigeria
Conditions:
HIV-1-infection
Eligibility:
All Genders
18-99 years
Brief Summary
D²EFT-GIC is a substudy of D²EFT study (NCT03017872), a randomised clinical trial of second-line antiretroviral therapies. The goal of D²EFT-GIC is to evaluate a novel tool, the "Graphical Informed Co...
Detailed Description
Informed consent requires provision of complex medical information in an easily understandable format. During the consent process, researchers may encounter potential research participants who are not...
Eligibility Criteria
Inclusion
- Fulfil the eligibility criteria for D²EFT and willing to undertake D²EFT informed consent process;
- Being able to give a verbal consent for the D²EFT-GIC.
Exclusion
- Unwilling to comply with the substudy requirements.
Key Trial Info
Start Date :
March 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04668443
Start Date
March 22 2021
End Date
December 31 2021
Last Update
January 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Human Virology Nigeria (IHVN)
Abuja, Nigeria